BDTX
Price
$3.80
Change
-$0.29 (-7.09%)
Updated
Oct 13 closing price
Capitalization
232.87M
27 days until earnings call
NUVL
Price
$86.56
Change
-$3.19 (-3.55%)
Updated
Oct 14, 11:51 AM (EDT)
Capitalization
6.47B
23 days until earnings call
Interact to see
Advertisement

BDTX vs NUVL

Header iconBDTX vs NUVL Comparison
Open Charts BDTX vs NUVLBanner chart's image
Black Diamond Therapeutics
Price$3.80
Change-$0.29 (-7.09%)
Volume$1.68M
Capitalization232.87M
Nuvalent
Price$86.56
Change-$3.19 (-3.55%)
Volume$100
Capitalization6.47B
BDTX vs NUVL Comparison Chart in %
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. NUVL commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and NUVL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (BDTX: $3.80 vs. NUVL: $89.75)
Brand notoriety: BDTX and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 170% vs. NUVL: 103%
Market capitalization -- BDTX: $232.87M vs. NUVL: $6.47B
BDTX [@Biotechnology] is valued at $232.87M. NUVL’s [@Biotechnology] market capitalization is $6.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while NUVL’s TA Score has 6 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 4 bearish.
  • NUVL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а -3.06% price change this week, while NUVL (@Biotechnology) price change was +7.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +80.86%.

Reported Earning Dates

BDTX is expected to report earnings on Nov 10, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($6.47B) has a higher market cap than BDTX($233M). BDTX YTD gains are higher at: 77.570 vs. NUVL (14.653). BDTX has higher annual earnings (EBITDA): 5.05M vs. NUVL (-362.01M). NUVL has more cash in the bank: 1.01B vs. BDTX (143M). BDTX has higher revenues than NUVL: BDTX (70M) vs NUVL (0).
BDTXNUVLBDTX / NUVL
Capitalization233M6.47B4%
EBITDA5.05M-362.01M-1%
Gain YTD77.57014.653529%
P/E Ratio15.83N/A-
Revenue70M0-
Total Cash143M1.01B14%
Total Debt20.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BDTXNUVL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEUFX63.560.78
+1.24%
American Funds EUPAC 529-F-1
IHOSX23.10N/A
N/A
Hartford International Opportunities R4
BMDSX19.66N/A
N/A
Baird Mid Cap Growth Investor
NMVLX12.15N/A
N/A
Nuance Mid Cap Value Institutional
PZVNX12.81N/A
N/A
Pzena International Value Investor

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-7.09%
RLAY - BDTX
54%
Loosely correlated
-3.54%
CGEM - BDTX
47%
Loosely correlated
+5.81%
NRIX - BDTX
47%
Loosely correlated
-0.41%
NUVL - BDTX
46%
Loosely correlated
+1.87%
CLDX - BDTX
46%
Loosely correlated
+1.34%
More